Comparative Pharmacology
Head-to-head clinical analysis: ANCEF versus CEFAZOLIN AND DEXTROSE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ANCEF versus CEFAZOLIN AND DEXTROSE.
ANCEF vs CEFAZOLIN AND DEXTROSE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
First-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking.
Bactericidal agent inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking, leading to cell lysis. Dextrose provides osmotic diuresis and energy source.
1-2 g IV/IM every 8 hours; maximum 6 g/day.
1-2 g IV/IM every 8 hours; maximum 12 g/day.
None Documented
None Documented
1.5-2 hours in adults with normal renal function; prolongs significantly in renal impairment (up to 30 hours in anuria).
1.8 hours (prolonged to 20-40 hours in severe renal impairment, CrCl <10 mL/min)
Primarily renal (80-90% unchanged by glomerular filtration and tubular secretion); small amounts biliary (<1%) and fecal.
Renal (80-90% unchanged via glomerular filtration and tubular secretion); biliary/fecal (<5%)
Category C
Category A/B
Cephalosporin Antibiotic
Cephalosporin Antibiotic